Cleveland Clinic study reveals kidney microbiome's role in renal health
Cleveland Clinic researchers have found definitive proof of a kidney microbiome that influences renal health and kidney stone formation, demonstrating ...
Tag: Preclinical
New immune therapy improves survival and reduces tumor burden in glioblastoma
The Wistar Institute's David B. Weiner, Ph.D. -; Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable ...
New initiative aims to explore diet’s role in lupus care
Lupus Therapeutics, the clinical affiliate of the Lupus Research Alliance (LRA), today announced a pioneering funding mechanism to address one of ...
Why predictive retina models could be the future of IND applications
In this interview, discover how retina models are revolutionizing rare disease treatment and accelerating drug development. What are the biggest ...
Kimchi found to significantly reduce body fat and combat obesity
Approximately 16% of the global population, or about 890 million people, suffer from obesity. The World Health Organization (WHO) has ...
GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder
A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use disorder hospitalizations, highlighting the potential ...
MD Anderson launches new institute for advancing cell therapy
The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & ...
Drug repurposing offers hope for SYNGAP1 patients
The SynGAP Research Fund 501(c)(3) has awarded a pair of grants to Dr. Clement Chow, a geneticist and Associate Professor ...
Researchers develop first-of-its-kind therapy to enhance heart repair after a heart attack
Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have developed a ...
Scientists uncover two Crohn’s disease subtypes using lab-grown intestines, offering hope for personalized therapies
By developing lab-grown intestines, researchers identified two unique molecular subtypes of Crohn’s disease, providing critical insights for personalized therapeutic approaches ...
